MSB 7.69% $1.19 mesoblast limited

The fact that this trial for Teva is only a minow of the...

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    The fact that this trial for Teva is only a minow of the portfolio size and the trial has passed all safety concerns to this point bodes well for Teva continuing the trial.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.